Literature DB >> 6339613

Expression of Ia antigen on epidermal keratinocytes after the grafting of normal skin to nude mice.

R A Daynes, M Emam, G G Krueger, L K Roberts.   

Abstract

During the course of experimentation designed to evaluate the migration of host Langerhans cells (LC) into normal skin grafted onto nude mice, we observed that the epidermal cells of these grafts were induced to express la determinants solely of graft origin. The data presented herein indicate that the expression of la by normal epidermal cells correlates with the infiltration of host LC into the graft. This la expression is restricted to the keratinocytes within the epidermis of the grafted skin, is first observed 7 to 9 days post-grafting, and persists within the grafted skin for greater than 12 wk. The induction of la expression by keratinocytes appears to be the result of the environment that is provided by the nude mouse host and is independent of both passenger lymphocytes within the skin graft and allogeneic differences between graft and host. We strongly believe that these studies provide the basis for the development of an experimental animal model system for investigating the potential role that la expression by epidermal cells may play in enhancing the immune response to antigens encountered in the skin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Different roles for cytosine methylation in HLA class II gene expression.

Authors:  F Levine; D Pious
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Survival of Allogeneic Self-Assembled Cultured Skin.

Authors:  Mihail Climov; Abraham J Matar; Evan A Farkash; Erika Medeiros; Jizeng Qiao; Edward Harrington; Ashley Gusha; Ahmad Al-Musa; David H Sachs; Mark Randolph; Thomas J Bollenbach; Christene A Huang
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

4.  Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.

Authors:  P Koldovsky; I Haas; H Bier; U Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.

Authors:  John M Centanni; Joely A Straseski; April Wicks; Jacquelyn A Hank; Cathy A Rasmussen; Mary A Lokuta; Michael J Schurr; Kevin N Foster; Lee D Faucher; Daniel M Caruso; Allen R Comer; B Lynn Allen-Hoffmann
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

6.  Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.

Authors:  R V Lloyd; T L Johnson; M Blaivas; J C Sisson; B S Wilson
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

7.  Immunoperoxidase staining for Ia-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma.

Authors:  B S Wilson; M A Herzig; R V Lloyd
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

8.  Graft-vs-host reactions induce H-2 class II gene transcription in host kidney cells.

Authors:  G D Sinclair; A Wadgymar; P F Halloran; T L Delovitch
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  The expression of Ia-antigen on nasopharyngeal carcinomas xenografted into nude mice.

Authors:  J Ebbers; P Koldovsky; K H Vosteen
Journal:  Arch Otorhinolaryngol       Date:  1985

10.  Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatoses.

Authors:  I A Lampert
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.